{"groups":[{"description":"Radiation therapy (64.8 Gy) + bicalutamide (150 mg daily 2 years)","id":"FG000","title":"Bicalutamide"},{"description":"Radiation therapy (64.8 Gy) + placebo (daily 2 years)","id":"FG001","title":"Placebo"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"1"}],"type":"Withdrawal by Subject"},{"reasons":[{"groupId":"FG000","numSubjects":"44"},{"groupId":"FG001","numSubjects":"34"}],"type":"Protocol Violation"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"421"},{"groupId":"FG001","numSubjects":"419"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"376"},{"groupId":"FG001","numSubjects":"384"}],"comment":"Subjects with data available for the primary analysis are considered to have completed the study.","type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"45"},{"groupId":"FG001","numSubjects":"35"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}